ELUTIA INC. - CLASS A
3.6900
06-November-24 14:59:50
15 minutes delayed
Stocks
-0.1400
-3.66%
Today's range
3.5150 - 3.8800
ISIN
N/A
Source
NASDAQ
-
Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024
29 Oct 2024 15:05:00 By Nasdaq GlobeNewswire
-
Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30
23 Oct 2024 15:05:00 By Nasdaq GlobeNewswire
-
18 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
06 Sep 2024 15:23:52 By Nasdaq GlobeNewswire
-
05 Sep 2024 15:05:00 By Nasdaq GlobeNewswire
-
Elutia to Participate in Upcoming Investor Conferences
03 Sep 2024 15:05:00 By Nasdaq GlobeNewswire
-
Elutia Announces Second Quarter 2024 Results
07 Aug 2024 15:05:01 By Nasdaq GlobeNewswire
-
Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds
01 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
-
Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
31 Jul 2024 15:05:00 By Nasdaq GlobeNewswire
-
Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
30 Jul 2024 15:05:00 By Nasdaq GlobeNewswire
-
Elutia to Present at the Emerging Growth Conference on Thursday, July 18
11 Jul 2024 15:05:00 By Nasdaq GlobeNewswire
-
Elutia Announces $13.26 Million Registered Direct Offering
17 Jun 2024 07:01:00 By Nasdaq GlobeNewswire
-
17 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024
13 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
09 May 2024 15:05:01 By Nasdaq GlobeNewswire
-
Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
02 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1
24 Apr 2024 15:05:00 By Nasdaq GlobeNewswire
-
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024
22 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
Elutia Regains Compliance with Nasdaq Listing Requirements
10 Jan 2024 15:05:00 By Nasdaq GlobeNewswire
-
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance
18 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >